Global High Flow Oxygen Cannula Market Outlook 2022

Nasal high flow oxygen therapy offers another option for patients requiring non-invasive respiratory support. Nasal high flow oxygen therapy allows delivery of a prescribed FiO2 with reduced air entrainment and dilution. This therapy may be beneficial in that nasal interfaces may be better tolerated and children receive the benefits of humidification and likely also receive a low level positive airway pressure.

The global High Flow Oxygen Cannula market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on High Flow Oxygen Cannula volume and value at the global level, regional level and company level. From a global perspective, this report represents overall High Flow Oxygen Cannula market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global High Flow Oxygen Cannula Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Pediatric
Adult

Segment by Application
Home Care
Hospitals
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Fisher & Paykel Healthcare
Vapotherm
ResMed
Teleflex
Salter Labs
Flexicare
Great Group Medical
Smiths Medical
medin Medical Innovations
Armstrong Medical